Bart Rijnders

Bart Rijnders is Full Professor at Erasmus Medical Center with joint appointments in Internal Medicine and Medical Microbiology & Infectious Diseases. His clinical research focuses on HIV, COVID-19, and viral hepatitis management.

Research includes longitudinal studies on COVID-19 vaccine responses in immunocompromised patients (2025), convalescent plasma therapy trials (2025), and hepatitis co-infection epidemiology (2025). Develops diagnostic protocols for fungal infections in hematological patients.

Publications demonstrate expertise in managing complex infectious disease cases and developing therapeutic interventions for vulnerable populations.